In conclusion, the current study demonstrates a molecular mechanism underlying circadian regulation of ANGPTL2 expression and provides insight into the pathogenesis of lifestyle-related diseases related to circadian disruption and inflammation. This evidence concerns the gene ANGPTL2 and glycogen storage disease VI.